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ABSTRACT
Despite the availability of free and anonymous HIV testing almost 60% of Swedish patients are
diagnosed late. Identifying predictors of different types of barriers could inform policy makers
and health care of interventions to increase testing where needed. This cross-sectional study
aimed to describe and analyze barriers to HIV testing as reported by Swedish patients newly
diagnosed with HIV infection. N = 285 patients completed the 18-item Barriers to HIV Testing
Scale – Karolinska Version. Descriptive analysis and logistic regressions were performed to
assess the prevalence of barriers and to identify predictors for the different investigated
barriers. Barriers to testing were reported by 60%. Approximately 67% of patients originating
from Sweden, 50% from Sub-Saharan Africa and 75% from Eastern European/East Asian
countries reported barriers. Patients who were younger and patients who self-initiated HIV
testing, had greater odds of reporting a barrier than older individuals and those who were
offered a test through screening or by a healthcare professional. To counteract barriers that still
exist on an individual level, healthcare-initiated HIV testing could be offered more broadly and
information about risks for transmission and effectiveness of HIV treatment still needs to be
disseminated among both people born in Sweden and different migrant groups.
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Introduction
HIV remains a public health problem in Europe. In
Sweden, around 8.000 people living with diagnosed
HIV (PLWH) are followed at 29 clinics. Of these, 98%
are on antiviral therapy, out of which 95% have
undetectable viral loads (HIV RNA<50 copies/mL),
i.e., effective virus therapy (Giardina et al., 2019; QRC
Stockholm, 2020). Sweden has world-class HIV care
and was the first country to report meeting the UNAIDS
90-90-90 diagnosis and treatment targets (Gisslén et al.,
2017). It estimated that the incidence of undiagnosed
HIV-1-infections among persons residing in Sweden
decreased by almost two-thirds from 2010 to approxi-
mately 10% 2015 (Public Health Agency of Sweden,
2015; Giardina et al., 2019). However, late presentation
still remains a significant problem; Swedish patients are
diagnosed at a late stage of HIV infection at a rate of
58% in comparison to their counterparts in the EU/
EEA at 51% (ECDC, 2017).
International and European guidelines call for
increasing the number of people diagnosed at an early
stage of infection (WHO, ECDC, 2017). In settings
such as Sweden, with low prevalence and with an epi-
demic concentrated in populations at increased risk,
the WHO recommends provider-initiated testing as
well as indicator-condition guided testing to all individ-
uals who present with symptoms that are clinically
associated with HIV (WHO, 2015). Research in Sweden
has recently described predictors which contribute to
late HIV testing in Sweden (Brännström, 2016). The
study demonstrated that missed opportunities at the
health systems level strongly contribute to late diag-
noses. Migrants, persons infected through heterosexual
transmission and persons aged over 40 all had higher
probability of late diagnosis. It is estimated that 19%
of migrants acquired HIV infection after arrival to Swe-
den (Brännström et al., 2017), which highlights that the
current strategy of offering HIV screening to all refugees
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upon arrival at health examinations is not enough to
identify HIV infection that occurs post-migration. Per-
sons diagnosed late who are not from key populations,
such as migrants and men who have sex with men, are
more likely to have a history of missed presentation at a
health care visit, to neglect symptoms of HIV, and are
less likely to self-initiate HIV testing (Brännström,
Johansson, et al., 2016; Brännström, Svedhem, et al.,
2016), indicating a low risk perception. The Swedish
national HIV strategy emphasizes the need to improve
overall HIV knowledge throughout all levels of the
Swedish healthcare system with the goal of increasing
provider-initiated testing (Public Health Agency of Swe-
den, 2017).
Despite excellent HIV care outcomes in Sweden,
increasing HIV testing and reducing the number of
late diagnoses persist as challenges in the Swedish
HIV epidemic, leading us to the importance of examin-
ing barriers from the test-takers’ perspective. Under-
standing what individual barriers are associated with
HIV-testing is essential to improve and expand current
HIV testing practices. The aim of the study was, there-
fore, to investigate barriers to HIV testing in a group of
newly diagnosed persons living with HIV in Sweden.
Specific research questions were:
(1) Do persons recently diagnosed with HIV report any
barrier to HIV testing?
(2) What risk indicators are associated with each of the
four categories of barriers: personal barriers, struc-
tural barriers, socio-economic barriers and barriers
related to confidentiality?
Materials and methods
Research design
This was a cross-sectional and descriptive quantitative
study.
Procedures
Eligible patients were informed about the study by their
health care provider during a routine clinic visit. After
giving written consent, participants completed a Swed-
ish or English version of a questionnaire (see below)
at the clinic. Interpreters were available by phone or
in person as needed. The study was approved by the
Regional ethics committee in Stockholm, Sweden
(record number 2009/1029-31/1-4 and 2014/928-31)
and by the Regional ethics committee in Gothenburg
(record number 532-11 amended 18/11/2011).
Measures
Barriers to HIV testing were assessed with the 18-item
Barriers to HIV Testing Scale – Karolinska version
(Table 1; Wiklander et al., 2015). Individuals could
choose one of three responses to 18 statements in the
barrier scale with respective scores: very important (2),
somewhat important (1) or not important (0). The
instrument covers four dimensions of barriers to HIV
testing: personal consequences (related to individual
fear such as fear of losing a partner and/or family and
friends, and fear of the result of an HIV test); structural
barriers (such as not having transportation to a testing
site, not knowing where to test, poor rapport with the
staff at the testing site); social and economic security
(fears of losing work, not being able to obtain insurance)
and; confidentiality (concerns about privacy, being
recognized at the testing site). Seven statements were
related to personal consequences, six statements were
related to structural barriers, three statements were
related to social and economic barriers and two state-
ments were related to confidentiality. Detailed socio-
demographic data was collected from the Swedish
national HIV registry InfCareHIV and through an
additional questionnaire In addition to the ordinal
and categorical data collected, the participants were
asked to answer one open ended question: What is the
main reason you did not test for HIV earlier?
Statistical analysis
Data was summarized using descriptive statistics in
SPSS version 25 (SPSS Inc, Chicago, U.S.A.). Socio-
demographic data were dichotomized or re-categorized
before further analysis, (Table 1). Cross-tabulations
with Chi-square were used to test for unadjusted
relationship between the outcome barrier and all par-
ticipant characteristics to determine which variables
were associated with reporting a barrier to testing. All
socio-demographic variables yielding a p < 0.20 from
Chi-square testing were included in the multivariate
logistic model using enter method.
Bivariate logistic regressions were performed to
assess the impact of several factors on the likelihood
that respondents would report any barrier and for the
respective barrier sub-categories. The model contained
10 independent variables: age, country of origin, accom-
modation, residence in a metropolitan area, religion
(respondents who reported that religion influenced
daily life), initiator of test, civil status, time since immi-
gration, previous thoughts about HIV and drug use. The
variable country of origin was described by four regions:
Sub-Saharan Africa, Sweden, East, Other. Sweden was
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Table 1. Descriptive and bivariate analysis of explanatory variables.
Characteristics
Total
N (%)
Barrier
Yes (%) P-value
Personal consequences
Yes (%)
Structural barriers
Yes (%)
Social and economical
Yes (%)
Confidentiality
Yes (%)
Total cohort 285 178 (62.5) 146 (51.2) 119 (41.8) 89 (31.2) 110 (38.6)
HIV stage
Non-LP 103 (36.1) 72 (66.0) 0.350 61 (59.2) 41 (39.8) 37 (35.9) 48 (46.6)
LP 182 (63.9) 110 (60.4) 85 (46.7) 78 (42.9) 52 (28.6) 62 (34.1)
Gender
Female 111 (39.0) 65 (58.6) 0.278 58 (52.3) 47 (42.3) 37 (33.3) 45 (40.5)
Male 174 (61.0) 113 (64.5) 88 (50.6) 72 (41.4) 52 (29.9) 65 (37.4)
Age (years)
<30 60 (21.1) 41 (68.3) 0.297 35 (58.3) 28 (46.7) 21 (35.0) 27 (45.0)
31–40 102 (35.8) 67 (65.7) 52 (51.0) 45 (44.1) 27 (26.5) 40 (39.2)
41–50 68 (23.9) 41 (60.3) 35 (51.5) 29 (42.7) 24 (35.3) 26 (38.2)
>50 55 (19.3) 29 (52.7) 24 (43.6) 17 (30.9) 17 (30.9) 17 (30.9)
Mean (SD) 40.5 (11.5) 39.7 (11.2) 0.090* 39.7 (11.3) 39.6 (11.4) 41.0 (11.7) 39.4 (11.6)
Route of transmission
Heterosexual 180 (63.2) 108 (60.0) 0.663 91 (50.6) 77 (42.8) 54 (30.0) 75 (41.7)
MSM 58 (20.4) 40 (69.0) 34 (58.6) 22 (37.9) 21 (36.2) 20 (34.5)
PWID 15 (5.3) 11 (73.3) 10 (66.7) 8 (53.3) 5 (33.3) 5 (33.3)
Unknown/other 32 (11.2) 19 (59.4) 11 (34.4) 12 (37.5) 9 (28.1) 10 (31.3)
Country of origin
Sweden 95 (33.3) 63 (66.3) 0.031* 53 (55.8) * 36 (37.9) * 26 (27.4) * 31 (32.6) *
SSA 122 (42.8) 64 (52.5) 50 (41.0) 45 (36.9) 30 (24.6) 41 (33.6)
East 36 (12.6) 28 (77.8) 26 (72.2) 22 (61.1) 18 (50.0) 22 (61.1)
Other 32 (11.2) 23 (71.9) 17 (53.1) 16 (50.0) 15 (46.9) 16 (50.0)
Country of transmission
Sweden 84 (29.5) 56 (66.7) 0.178* 51 (60.7) * 33 (39.3) 23 (27.4) 32 (38.1)
SSA 102 (35.8) 54 (52.9) 41 (40.2) 40 (39.2) 26 (25.5) 35 (34.3)
East 54 (19.0) 37 (68.5) 32 (59.3) 30 (55.6) 23 (42.6) 28 (51.9)
Other 45 (15.8) 31 (68.9) 22 (48.9) 16 (35.6) 17 (37.8) 15 (33.3)
Immigration time
Swedish 95 (33.3) 63 (66.3) 0.196* 53 (55.8) 36 (37.9) 26 (27.4) 31 (32.6)
< 2 months 40 (14.0) 20 (50.0) 12 (30.0) 17 (42.5) 8 (20.0) 13 (32.5)
2 months to <1 year 56 (19.7) 30 (53.6) 24 (42.9) 24 (42.9) 19 (33.9) 18 (32.1)
1–5 years 45 (15.8) 30 (66.7) 26 (58.8) 20 (44.4) 18 (40.0) 25 (55.6)
>5 years 47 (16.5) 34 (72.3) 31 (66.0) 22 (46.8) 17 (36.2) 22 (46.8)
Unknown 2 (0.7) 1 (50.0) 0 (0.00) 0 (0.00) 1 (50.0) 1 (50.0)
Education level
None 26 (9.1) 17 (65.4) 0.941 13 (50.0) 11 (42.3) 10 (38.5) 9 (34.6)
Pre-secondary school 75 (26.3) 44 (58.7) 34 (45.3) 36 (48.0) 25 (33.3) 24 (32.0)
Secondary school 93 (32.6) 58 (62.4) 52 (55.9) 33 (35.5) 27 (29.0) 38 (40.9)
Post-secondary school 88 (30.9) 57 (64.8) 45 (51.4) 37 (42.1) 26 (29.6) 38 (43.2)
Unknown 3 (1.1) 2 (66.7) 2 (66.7) 2 (66.7) 1 (33.3) 1 (33.3)
Source of income
Own salary 122 (42.8) 82 (67.2) 0.357 68 (55.7) 45 (36.9) 37 (30.3) 49 (40.2)
Other 158 (55.4) 93 (58.9) 76 (48.1) 71 (44.9) 50 (31.6) 59 (37.3)
Unknown 5 (1.8) 3 (60.0) 2 (40.0) 3 (60.0) 2 (40.0) 2 (40.0)
Accommodation
Own 178 (62.5) 116 (65.2) 0.026* 95 (53.4) 70 (39.3) 61 (34.3) 66 (37.1)
2nd hand/family 60 (21.1) 35 (58.3) 29 (48.3) 29 (48.3) 15 (25.0) 27 (45.0)
By authorities 23 (8.1) 15 (65.2) 13 (56.5) 11 (47.8) 5 (21.7) 9 (39.1)
Refugee camp 19 (6.7) 7 (36.8) 5 (26.3) 5 (26.3) 5 (26.3) 5 (26.3)
Homeless/jail 5 (1.8) 5 (100.0) 4 (80.0) 4 (80.0) 3 (60.0) 3 (60.0)
Civil status
Single/divorced/widow 111 (39.0) 70 (63.1) 0.004* 56 (50.4) 41 (36.9) 28 (25.2) 38 (34.2)
Cohabiter/live-apart 75 (26.3) 57 (76.0) 52 (69.3) 40 (53.3) 32 (42.7) 41 (54.7)
Married/reg. partner 99 (34.7) 51 (51.5) 38 (38.4) 38 (38.4) 29 (29.3) 31 (31.3)
Children
No 105 (36.8) 66 (62.9) 0.454 55 (52.4) 45 (42.9) 27 (25.7) 43 (41.0)
Yes 160 (56.1) 97 (60.6) 79 (49.4) 66 (41.3) 55 (34.4) 58 (36.2)
Unknown 20 (7.0) 15 (75.0) 12 (60.0) 8 (40.0) 7 (35.0) 9 (45.0)
Metropolitan area
No 83 (29.1) 45 (54.2) 0.066* 31 (37.4) 34 (41.0) 23 (27.7) 27 (32.5)
Yes 202 (70.9) 133 (65.8) 115 (56.9) 85 (42.1) 66 (32.7) 83 (41.1)
Migration status
Non migrant 95 (33.3) 63 (66.3) 0.011* 53 (55.8) 36 (37.9) 26 (27.4) 31 (32.6)
Refugee 85 (29.8) 42 (49.4) 30 (35.3) 34 (40.0) 19 (22.4) 30 (35.3)
Other 105 (36.8) 73 (69.5) 63 (60.0) 49 (46.7) 44 (41.9) 49 (46.7)
Religion affecting daily life
No 179 (62.8) 118 (65.9) 0.075* 101 (56.4) 77 (43.0) 63 (35.2) 74 (41.3)
Yes 90 (31.6) 48 (53.3) 34 (37.8) 34 (37.8) 20 (22.2) 30 (33.3)
Unknown 16 (5.6) 12 (75.0) 11 (68.8) 8 (50.0) 6 (37.5) 6 (37.5)
(Continued )
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used as the reference. The variables “migration status”
and “country of transmission” were removed since cor-
relation testing demonstrated a strong multicollinearity
with other variables. Adjusted odd ratios with 95%
confidence intervals were presented in the final model.
Confidentiality was maintained throughout data collec-
tion and analysis.
Qualitative analysis
In order to enrich and deepen the results obtained by
the quantitative data the participants’ answers on the
open-ended question were analyzed by descriptive con-
tent analysis (Vaismoradi et al., 2013).
Results
Sample characteristics
Participants were consecutively recruited from eleven
HIV clinics throughout Sweden from 1 October 2009
to 31 January 2012. All patients, aged 18 or above, diag-
nosed with HIV-1 within the last six months were eli-
gible to participate in the study (n = 445). The
questionnaire was completed by 292 adults recently
diagnosed with HIV infection and 285 had complete
data and were included in the analyses, representing
64% of eligible patients at the eleven study clinics (see
Table 1). The mean age of the study population was
40.5 (SD 11.5) and the majority of the participants
(61%) were men. Over 75% of the participants reported
a country of origin other than Sweden, with origin from
Sub-Saharan Africa dominating the sample (42.8%).
HIV acquired through heterosexual contact was the
most common mode of transmission, reported by 63%
of participants. Late presentation was common at 64%
and as many as 40% with advanced HIV infection
(defined as CD4 count <200 × 106/ml or diagnosis of
AIDS-defining condition). Only 16% of testing was
patient-initiated while the majority of testing was
initiated by a health care provider based on screening
guidelines or due to symptoms (Table 1).
Study participants (n = 285) did not differ from the
total number of participants who were eligible to par-
ticipate in the present study, (n = 445) regarding sex,
age or route of transmission, but participants were less
likely to be born outside of Sweden (OR 0.51, CI 95%,
0.32–0.80, p = 0.0004). Furthermore, the study partici-
pants were representative of the total population of indi-
viduals newly diagnosed with HIV in Sweden during the
study period (n = 827), regarding sex and origin, but
were slightly older (mean age 40.5 vs. 38.9, t [2.84], p
= 0.020), and had a lower representation of individuals
with men who have sex with men (MSM) as route of
transmission (OR 0.68, CI 95% 0.49–.94, p = 0.018).
Descriptive statistics of barriers to HIV testing
Two-thirds of the participants reported some/any type
of barrier to HIV testing; personal barriers (51%), struc-
tural barriers (42%), socio-economic barriers (31%) and
barriers related to confidentiality (39%, see Table 1).
Amongst the specific items, fears around becoming ill,
Table 1. Continued.
Characteristics
Total
N (%)
Barrier
Yes (%) P-value
Personal consequences
Yes (%)
Structural barriers
Yes (%)
Social and economical
Yes (%)
Confidentiality
Yes (%)
Psychiatric illness
No 253 (88.8) 157 (62.1) 0.694 128 (50.6) 108 (42.7) 79 (31.2) 101 (39.9)
Yes 32 (11.2) 21 (65.6) 18 (56.2) 11 (34.4) 10 (31.3) 9 (28.1)
Drug use
No 231 (81.0) 140 (60.6) 0.182* 112 (48.5) 97 (42.0) 71 (30.7) 90 (39.0)
Yes 54 (19.0) 38 (70.4) 34 (63.0) 22 (40.7) 18 (33.3) 20 (37.0)
Previous thoughts of HIV
No 209 (73.3) 123 (58.8) 0.112* 97 (46.4) 87 (41.6) 58 (27.8) 79 (37.8)
Yes 66 (23.2) 48 (72.7) 43 (65.2) 27 (40.9) 27 (40.9) 27 (40.9)
Unknown 10 (3.5) 7 (70.0) 6 (60.0) 5 (50.0) 4 (40.0) 4 (40.0)
Neglect of symptoms
No 247 (86.7) 151 (61.1) 0.240 124 (50.2) 105 (42.5) 77 (31.2) 98 (39.7)
Yes 38 (13.3) 27 (71.0) 22 (57.9) 14 (36.8) 12 (31.6) 12 (31.6)
Previous negative test
No 176 (61.8) 107 (60.8) 0.755 88 (50.0) 70 (39.8) 51 (29.0) 67 (38.1)
Yes 91 (31.9) 59 (64.8) 48 (52.8) 42 (46.2) 33 (36.3) 34 (37.4)
Unknown 18 (6.3) 12 (66.7) 10 (55.6) 7 (38.9) 5 (27.8) 9 (50.0)
Initiator of testing
Patient 46 (16.1) 38 (82.6) 0.002* 32 (69.6) 27 (58.7) 24 (52.2) 22 (47.8)
Physician: symptom 97 (34.0) 57 (58.8) 49 (50.5) 37 (38.1) 29 (29.9) 33 (34.0)
Screening high prev gr 80 (28.1) 43 (53.8) 32 (40.0) 29 (36.3) 20 (25.0) 29 (36.3)
Screening other 60 (21.1) 39 (65.0) 32 (53.3) 25 (41.7) 15 (25.0) 25 (41.7)
Unknown 2 (0.7) 1 (50.0) 1 (50.0) 1 (50.0) 1 (50.0) 1 (50.0)
Note. *A p-value of <0.20 was considered significant for inclusion in the regression models.
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feeling like a failure, confidentiality and effects on sex
life were the most commonly reported barriers to testing
(see Table 2).
Approximately two-thirds of Swedish patients
reported a barrier compared to half of patients orig-
inating from Sub-Saharan Africa, while as many as
three-fourths from Eastern European/East Asian
countries reported one or more barriers to HIV testing
(Table 2). Patients who were offered an HIV test by a
healthcare provider were less likely to report any
barrier to testing (p = 0.022). For migrants, there
appeared to be a trend, although not statistically sig-
nificant, towards more barriers the longer time has
passed from arrival to Sweden. Half of migrants who
tested within one year of arrival reported barriers com-
pared to two thirds among those having resided >1
year in Sweden. The latter was equivalent to barriers
reported among Swedish born patients. In line with
this the proportion with barriers was lower among
patients with refugee status, living in refugee camps
(who are routinely offered HIV testing through
national screening programs).
Predictors for barriers to HIV testing
Lower odds of reporting any barrier were shown with
increasing age (OR 0.972, 95% CI 0.948–0.997, p =
0.030) and among those who were offered a HIV test
by a healthcare provider (OR 0.370, 95% CI, 0.153–
0.894, p = 0.027). Lower odds for reporting a structural
barrier were also seen when testing was initiated by a
healthcare provider compared to self-initiated HIV test-
ing (OR 0.365, 95% CI 0.172–0.776, p = 0.009), see
Table 3.
Predictors for individual barriers according to
origin and religion
Predictors for personal barriers are presented in Table 3.
Predictors for reporting a personal barrier were origin
from Sub-Saharan Africa (OR 2.880, 95% CI 1.023–
8.107, p = 0.045). Living in a non-metropolitan area
also increased the odds of reporting a personal barrier
(OR 2.121, CI 95% 1.043–4.311, p = 0.038). Lower
odds for reporting a personal barrier were seen in
those who reported that religion affected daily life (OR
0.503, CI 95% 0.265–0.954, p = 0.035). Predictors in
the barrier sub-category confidentiality were origin in
Sub-Saharan Africa (OR 3.175, CI 95% 1.037–9.720, p
= 0.043).
Persons who reported that religion affected daily life
(OR 0.429, CI 95% 0.210–0.875, p = 0.020,) or for whom
HIV test was initiated by a healthcare provider (OR
0.433, CI 95% 0.207–0.905, p = 0.026) had lower odds
for reporting a socioeconomic barrier to testing. Non-
Swedish born patients (“Other” in the tables), originat-
ing mainly from countries with low HIV prevalence (as
opposed to Sub Saharan Africa and East) had higher
odds of reporting barriers related to socioeconomic con-
sequences than those born in Sweden.
Reasons for not testing for HIV
A total of 197 (67%) of the study participants answered
the open-ended question about the reason for not test-
ing for HIV earlier. The qualitative content analysis of
the open-ended answers resulted in seven categories,
which together with examples of significant comments
are shown in Table 4. The results show that
Table 2. Descriptive statistics of items in the Barriers to HIV Testing Scale – Karolinska version, possible range 0–2, higher levels
indicating stronger agreement.
Barriers to HIV-testinga N Mean SDb Total N (%) with barrier
16. I was afraid of becoming sick 284 0.70 0.890 116 (40.8)
18. I was worried about feeling like a failure 282 0.51 0.810 86 (30.5)
6. I was worried about confidentiality 280 0.50 0.790 87 (31.1)
15. I was afraid that my sex life would be negatively affected 282 0.48 0.765 89 (31.6)
14. I was afraid of losing my friends and other social contacts 283 0.47 0.773 83 (29.3)
7. People might recognize me at testing site 281 0.45 0.741 85 (30.2)
9. I did not want to know the results 284 0.42 0.736 78 (27.5)
13. I was afraid of losing my family 282 0.42 0.765 70 (24.8)
12. I was afraid of losing my partner 283 0.40 0.724 73 (25.8)
2. I did not know where to go for testing 285 0.34 0.676 63 (22.1)
17. I was worried about the legal consequences 277 0.32 0.670 56 (20.2)
11. I was afraid of losing my job 281 0.30 0.661 51 (18.1)
8. There was no cure so why get tested 283 0.29 0.653 51 (18.0)
1. I did not have transportation to a testing site 285 0.28 0.634 53 (18.6)
3. I did not have enough time 284 0.23 0.583 42 (14.8)
10. I was worried about my insurance/insurances 281 0.20 0.550 36 (12.8)
4. The testing site was too far away 281 0.15 0.443 31 (11.0)
5. I did not like the people at testing site 280 0.15 0.478 28 (10.0)
aItem number in the HIV-testing scale – Karolinska Version.
bRange 0–2; SD = standard deviation.
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Table 3. Logistic regression of determinants to barriers to HIV testing (n=285).
Variable
Any barrier Structural Personal Confidentiality Socioeconomic
Adjusted OR
(95% CI) P-value
Adjusted OR
(95% CI) P-value
Adjusted OR
(95% CI) P-value
Adjusted OR
(95% CI) P-value
Adjusted OR
(95% CI) P-value
Age 0.972
(0.948–0.997)
0.030* 0.989
(0.964–1.013)
0.364 0.975
(0.949–1.001)
0.057 0.994
(0.968–1.020)
0.646 1.018
(0.990–1.047)
0.213
Country of origin
Sweden Ref Ref Ref Ref Ref
Sub-Saharan Africa 0.513
(0.186–1.416)
0.197 1.879
(0.661–5.344)
0.740 3.620 (1.061–12.354) 0.040* 3.175
(1.037–9.720)
0.043* 1.476
(0.526–4141)
0.460
East 0.903
(0.261–3.127)
0.872 1.879
(0.661–5.344)
0.237 1.054
(0.398–2.794)
0.915 0.672
(0.260–1.738)
0.412 2.792
(1.006–7.700)
0.049*
Other 0.871
(0.251–4.124)
0.772 2.201
(0.832–5.821)
0.112 1.883
(0.587–6.134)
0.294 1.348
(0.453–4.016)
0.592 2.690
(0.961–7.534)
0.060
Religion affecting daily life
No/unknown Ref Ref Ref Ref Ref
Yes 0.367 0.939
(0.494–1.786)
0.849 0.509
(0.260–0.994)
0.048* 0.732
(0.379–1.413)
0.352 0.410
(0.191–0.840)
0.015*
Immigration time
Swedish Ref Ref Ref Ref Ref
2 months-1 year 1.219
(0.382–3.889)
0.738 0.351
(0.099–1.240)
0.104 0.374
(0.146–0.959)
0.041* 1.346
(0.452–4.003)
0.594 1.434
(0.363–5.669)
0.607
>1year-5 years 1.877
(0.540–6.522)
0.322 0.391
(0.111–1.382)
0.145 1.334
(0.405–4.319)
0.636 3.325
(1.050–10.526)
0.041* 2.596
(0.658–10.240)
0.173
>5 years 2.353
(0.798–6.935)
0.121 0.157 1.975
(0.715–5.453)
0.189 2.239
(0.848–5.910)
0.104 0.930
(0.249–3.476)
0.915
Accommodation
Own Ref Ref Ref Ref Ref
2nd hand or family 2.182
(0.796–5.997)
0.129 0.921
(0.256–3.305)
0.899 2.815
(1.031–7.786)
0.043* 2.509
(0.973–6.469)
0.057 1.038
(0.373–2.888)
0.943
By authorities, homeless or jail 0.742
(0.353–1.559)
0.430 1.834
(0.844–3.806)
0.103 0.856
(0.408–1.797)
0.681 1.576
(0.748–3.232)
0.232 0.649
(0.284–1.484)
0.306
Refugee housing 0.692
(0.205–2.338)
0.554 2.599
(1.035–6.525)
0.042* 2.933
(1.057–8.137)
0.039* 1.699
(0.458–6.301)
0.428 1.351
(0.327–5.578)
0.677
Civil status
Single Ref Ref Ref Ref Ref
Civil partnership 1.504
(0.717–3.115)
0.208 1.823
(0.916–3.628)
0.087 2.390
(1.151–4.959)
0.019* 2.174
(1.080–4.377)
0.030* 1.641
(0.786–3.428)
0.187
Married 0.868
(0.420–1.793)
0.703 1.317
(0.642–2.704)
0.452 0.957
(0.463–1.977)
0.905 1.074
(0.515–2.237)
0.850 1.478
(0.666–3.280)
0.337
Metropolitan area
Yes Ref Ref Ref Ref Ref
No 1.217
(0.603–2.456)
0.584 0.908
(0.461–1.786)
0.849 0.424
(0.210–0.856)
0.017* 1.542
(0.751–3.165)
0.238 1.415
(0.654–3.063)
0.378
(Continued )
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approximately 25% of the patients had never considered
an HIV diagnosis and 25% had previously tested nega-
tive and, therefore did not believe there was a risk for
acquiring HIV infection (Table 4).
Discussion
All types of barriers found amongst all groups
In this study of recently diagnosed patients with HIV,
over 60% reported at least one barrier to testing, despite
the availability of free and anonymous testing in Swe-
den. This confirms findings from other studies in
high-income countries where people continue to test
late even when HIV testing is free and anonymous
(Gardner et al., 2016; Schwarcz et al., 2011). Although
persons from Sub-Saharan Africa, refugees and certain
other migrant groups are often included in national
HIV testing programs, these groups continued to report
barriers. This can inform and improve current HIV test-
ing strategies at the public health level. In this study,
persons who considered religion affecting daily life,
reported fewer socio-economic and personal barriers
to testing. Previous research has shown that religion
and spirituality can function both as barriers and facil-
itators to treatment for HIV (Kendrick, 2017). Personal
barriers yielded two predictors to testing, with persons
residing outside of metropolitan areas and persons
from Sub-Saharan Africa reporting greater barriers of
this kind. Limited options to test in rural areas may
lead to delays in testing, an area that needs to be further
investigated in the Swedish context and whether
implementation of indicator-guided testing in Sweden
could lead to earlier HIV diagnosis.
Benefits of early HIV diagnosis – increasing
overall public knowledge
This study also confirmed that fears related to becoming
sick continue to contribute to delaying or avoiding HIV
testing. This response emerged clearly in the qualitative
analysis, which revealed that 25% of respondents
delayed testing due to fear. Fear and fatalistic attitudes
towards a variety of health conditions are cited in pre-
vious literature as reasons given for delaying contact
with a health care provider (Kannan & Veazie, 2014).
Campaigns and messaging by public health agencies
and other organizations should especially emphasize
that early diagnosis of HIV dramatically improves prog-
nosis and include information about where testing is
available (Schwarcz et al., 2011). HIV is now considered
a chronic and manageable condition and most people
living with HIV in settings with general access to highTa
bl
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quality care and treatment, like Sweden, live without
symptoms of HIV infection but are also unfortunately
diagnosed late (Brännström, 2016). It is therefore of
essence that this information is widely spread in order
to minimize this barrier to testing. In addition, HIV-
related stigma is a barrier to testing that emerged in
the content analysis. Despite fear of HIV these individ-
uals have consented to HIV testing which shows that
provider-initiated testing could be one measure to
address this barrier to testing. Expanding provider-
initiated testing using clinical indications for testing is
recommended by the European Centers for Disease
Control (ECDC, 2017) as a concrete way to circumvent
fear and stigma by normalizing HIV testing in primary
care settings.
Opt-out testing is HIV testing, automatically
included in routine care, for example in emergency
care settings and patients must actively decline a test.
It has been an effective way to increase uptake of HIV
testing in the US, although many countries in Europe
still prefer targeted testing, also known as indicator-
guided testing. Indicator-guided testing entails broadly
testing for HIV when patients present in healthcare set-
tings with conditions that are associated with undiag-
nosed HIV infection such as having a sexual
transmitted infection, oral thrush and other symptoms
of a compromised immune system (Eurotest, 2014;
Montoy et al., 2016). HIV testing outside of traditional
settings such as sexual health clinics can also improve
testing uptake since neutral settings can be less stigma-
tizing (Croxford et al., 2017).
Poor knowledge about what constitutes a risk for
HIV was revealed in the open-ended question and
many respondents did not correlate their own behavior
with risk for HIV, leading to delays or avoidance of HIV
testing. This also confirms previous research, which has
identified low perceived risk as a major barrier to HIV
testing at the individual level (Schwarcz et al., 2011).
A study from Tanzania show that partners had low
knowledge about their partner’s HIV-status and 96%
had not disclosed their own HIV-status due to fear of
divorce (Hallberg et al., 2019). This confirms the results
of the present study: increasing overall public knowl-
edge about HIV remains an ongoing priority and dis-
mantling stereotypes about what defines HIV risk is
needed to encourage testing.
Concluding remarks
The findings of this study contribute to previous
research that significant barriers to HIV testing remain
at the patient level. Since this was a cross-sectional
study, associations between different variables can be
found but these should not be interpreted as causal
effects. One limitation with this study is that it examined
barriers amongst individuals who were already diag-
nosed with HIV infection and may not be generalizable
to persons who have not acquired HIV or persons who
have not yet tested. Since barriers were reported after
diagnosis it may be a challenge for people to retrospec-
tively recall specific barriers to testing. A significant
strength of the study is that it includes the persons we
aim to reach with HIV testing since they were found
to be HIV positive. These individuals are the ones we
want to learn more about; specifically, about the barriers
they have experienced and have shared through this
study. This research therefore adds a piece to the com-
plex puzzle of understanding barriers to HIV testing.
Recommendations for future research
These results can likely inform other high-income set-
tings where HIV testing is free: barriers remain amongst
all groups and most importantly, in groups that are both
included and not included in target screening programs.
Future research might include studies that administer a
questionnaire or interview at the time of testing and in
Table 4. Reasons for not testing for HIV by individuals newly diagnosed with HIV infection.
Reasons N = 197 % Example of open answers
Did not believe they had a reason
to test
52 26 “Never had a thought of being infected”; “I did not think that I could be infected”; “Didn’t think I was in a
risk group”.
Earlier negative test 48 24 “Tested myself a couple of times”; “Two years ago, I was tested in my country – negative”
No symptoms – felt healthy 39 20 “Everything felt fine with the body. Worked and was healthy”; “Never been ill, healthy and have never
had any contacts with the healthcare. Feeling well”; “I had no problems. No disease”
Only one or few partners, or had
protected sex
24 12 “Have only been with one man, trusted him”; “Never thought she could be infected”; “ Practiced safe sex,
always used a condom”
Fear of a positive test result 17 9 “Stigma. Fear of what having HIV brings”; “Didn’t want to believe it. Postpone the decision”; “Fear of
finding out the truth”
Other reasons, i.e., lack of
knowledge
9 5 “Didn’t think I could get HIV as I was convinced that only homosexual could get it”; “Thought that a test
was taken when admitted to hospital at the reproductive health clinic for surgical treatment of a
gynecological condition”
No opportunity to take an HIV-test 8 4 “Not common routine in my country”; “Didn’t know where to go for testing in Sweden, waited until I got
back to Thailand for holiday”.
8 L. GEORGE-SVAHN ET AL.
different settings to identify both motivators and bar-
riers to HIV testing.
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